To identify additional MLH1 epimutation cases, blood-based MLH1 methylation testing was performed on the seven non-Lynch syndrome cases without sufficient tumour DNA but no additional MLH1 epimutation cases were identified (Fig. 1). The gene discussed is MLH1; the disease is neoplasm.